Stay updated on Nivolumab Plus Ipilimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 reference removed.
    Difference
    3%
    Check dated 2025-10-06T16:07:33.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T10:09:01.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-15T01:11:38.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T23:00:20.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations across various countries, while removing previous location details and some related medical topics.
    Difference
    3%
    Check dated 2025-08-31T19:52:15.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T12:33:22.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.